Scheller, Carsten <br/><br/>
Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95.  [electronic resource] 

 -  The Journal of biological chemistry  May 2002 
 - 15459-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9258 
<br/><br/><label>Standard No.: </label>10.1074/jbc.M200763200  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD--physiology<br/>Caspase Inhibitors<br/>Cell Line<br/>Cell Nucleus--drug effects<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>HIV--drug effects<br/>Humans<br/>NF-kappa B--metabolism<br/>Receptors, Tumor Necrosis Factor--physiology<br/>Receptors, Tumor Necrosis Factor, Type I<br/>T-Lymphocytes<br/>Tumor Necrosis Factor-alpha--genetics<br/>Virus Activation--drug effects<br/>Virus Replication--physiology<br/>fas Receptor--immunology